Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Emergence of the C1-M27 cluster in ST131 Escherichia coli from companion animals in France.

Melo LC, Haenni M, Saras E, Duprilot M, Nicolas-Chanoine MH, Madec JY.

J Antimicrob Chemother. 2019 Oct 1;74(10):3111-3113. doi: 10.1093/jac/dkz304. No abstract available.

PMID:
31299071
2.

Association Between Kinetics of Early Biofilm Formation and Clonal Lineage in Escherichia coli.

Flament-Simon SC, Duprilot M, Mayer N, García V, Alonso MP, Blanco J, Nicolas-Chanoine MH.

Front Microbiol. 2019 May 31;10:1183. doi: 10.3389/fmicb.2019.01183. eCollection 2019.

3.

Independent Host Factors and Bacterial Genetic Determinants of the Emergence and Dominance of Escherichia coli Sequence Type 131 CTX-M-27 in a Community Pediatric Cohort Study.

Birgy A, Levy C, Nicolas-Chanoine MH, Cointe A, Hobson CA, Magnan M, Bechet S, Bidet P, Cohen R, Bonacorsi S.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00382-19. doi: 10.1128/AAC.00382-19. Print 2019 Jul.

PMID:
31085515
4.

Evaluation of the culture-enhanced Xpert MTB/RIF assay for the diagnosis of smear-negative tuberculosis.

Noussair L, Bert F, Leflon-Guibout V, Métivier R, Chauvet C, Napol C, Nicolas-Chanoine MH.

Med Mal Infect. 2019 Sep;49(6):467-470. doi: 10.1016/j.medmal.2018.11.004. Epub 2018 Dec 6.

PMID:
30528069
5.

Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.

Nicolas-Chanoine MH, Vigan M, Laouénan C, Robert J; “E-carb Study Group”.

Eur J Clin Microbiol Infect Dis. 2019 Feb;38(2):383-393. doi: 10.1007/s10096-018-3438-9. Epub 2018 Nov 28.

PMID:
30488368
6.

Interplay Between Membrane Permeability and Enzymatic Barrier Leads to Antibiotic-Dependent Resistance in Klebsiella Pneumoniae.

Nicolas-Chanoine MH, Mayer N, Guyot K, Dumont E, Pagès JM.

Front Microbiol. 2018 Jun 29;9:1422. doi: 10.3389/fmicb.2018.01422. eCollection 2018.

7.

Emergence of plasmid-mediated colistin resistance (mcr-1) among Enterobacteriaceae strains: Laboratory detection of resistance and measures to control its dissemination.

Lepelletier D, Bonnet R, Plésiat P, Nicolas-Chanoine MH, Berger-Carbonne A, Chidiac C, Grandbastien B; national working group from the French High Council of Public Health.

Med Mal Infect. 2018 Jun;48(4):250-255. doi: 10.1016/j.medmal.2018.01.010. Epub 2018 Feb 21.

PMID:
29475568
8.

Hypervirulent Klebsiella pneumoniae in Cryptogenic Liver Abscesses, Paris, France.

Rossi B, Gasperini ML, Leflon-Guibout V, Gioanni A, de Lastours V, Rossi G, Dokmak S, Ronot M, Roux O, Nicolas-Chanoine MH, Fantin B, Lefort A.

Emerg Infect Dis. 2018 Feb;24(2):221-229. doi: 10.3201/eid2402.170957.

9.

In-vivo loss of carbapenem resistance by extensively drug-resistant Klebsiella pneumoniae during treatment via porin expression modification.

Bialek-Davenet S, Mayer N, Vergalli J, Duprilot M, Brisse S, Pagès JM, Nicolas-Chanoine MH.

Sci Rep. 2017 Jul 27;7(1):6722. doi: 10.1038/s41598-017-06503-6.

10.

The ST131 Escherichia coli H22 subclone from human intestinal microbiota: Comparison of genomic and phenotypic traits with those of the globally successful H30 subclone.

Nicolas-Chanoine MH, Petitjean M, Mora A, Mayer N, Lavigne JP, Boulet O, Leflon-Guibout V, Blanco J, Hocquet D.

BMC Microbiol. 2017 Mar 27;17(1):71. doi: 10.1186/s12866-017-0984-8.

11.

Development of an algorithm for phenotypic screening of carbapenemase-producing Enterobacteriaceae in the routine laboratory.

Robert J, Pantel A, Merens A, Meiller E, Lavigne JP, Nicolas-Chanoine MH; ONERBA’s carbapenem resistance study group.

BMC Infect Dis. 2017 Jan 17;17(1):78. doi: 10.1186/s12879-016-2174-y.

12.

Trends of extended-spectrum β-lactamase-producing Escherichia coli sequence type 131 and its H30 subclone in a French hospital over a 15-year period.

Sauget M, Cholley P, Vannier A, Thouverez M, Nicolas-Chanoine MH, Hocquet D, Bertrand X.

Int J Antimicrob Agents. 2016 Dec;48(6):744-747. doi: 10.1016/j.ijantimicag.2016.09.023. Epub 2016 Nov 4.

PMID:
27836379
13.

The challenges of multi-drug-resistance in hepatology.

Fernández J, Bert F, Nicolas-Chanoine MH.

J Hepatol. 2016 Nov;65(5):1043-1054. doi: 10.1016/j.jhep.2016.08.006. Epub 2016 Aug 17. Review.

PMID:
27544545
14.

Modulation of Membrane Influx and Efflux in Escherichia coli Sequence Type 131 Has an Impact on Bacterial Motility, Biofilm Formation, and Virulence in a Caenorhabditis elegans Model.

Pantel A, Dunyach-Remy C, Ngba Essebe C, Mesureur J, Sotto A, Pagès JM, Nicolas-Chanoine MH, Lavigne JP.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):2901-11. doi: 10.1128/AAC.02872-15. Print 2016 May.

15.

Costs associated with implementation of a strict policy for controlling spread of highly resistant microorganisms in France.

Birgand G, Leroy C, Nerome S, Luong Nguyen LB, Lolom I, Armand-Lefevre L, Ciotti C, Lecorre B, Marcade G, Fihman V, Nicolas-Chanoine MH, Pelat C, Perozziello A, Fantin B, Yazdanpanah Y, Ricard JD, Lucet JC.

BMJ Open. 2016 Jan 29;6(1):e009029. doi: 10.1136/bmjopen-2015-009029.

16.

A new mechanism to render clinical isolates of Escherichia coli non-susceptible to imipenem: substitutions in the PBP2 penicillin-binding domain.

Aissa N, Mayer N, Bert F, Labia R, Lozniewski A, Nicolas-Chanoine MH.

J Antimicrob Chemother. 2016 Jan;71(1):76-9. doi: 10.1093/jac/dkv318. Epub 2015 Oct 12.

PMID:
26462991
17.

High prevalence of the animal-associated bla CTX-M-1 IncI1/ST3 plasmid in human Escherichia coli isolates.

Madec JY, Haenni M, Métayer V, Saras E, Nicolas-Chanoine MH.

Antimicrob Agents Chemother. 2015 Sep;59(9):5860-1. doi: 10.1128/AAC.00819-15. Epub 2015 Jun 29. No abstract available.

18.

Genetic, biochemical characterization and mutagenesis of the chromosomal class A β-lactamase of Raoultella (formerly Klebsiella) terrigena.

Walckenaer E, Delmas J, Leflon-Guibout V, Bonnet R, Nicolas-Chanoine MH.

Pathol Biol (Paris). 2015 Sep;63(4-5):158-63. doi: 10.1016/j.patbio.2015.05.002. Epub 2015 Jun 16.

PMID:
26092758
19.

Genomic definition of hypervirulent and multidrug-resistant Klebsiella pneumoniae clonal groups.

Bialek-Davenet S, Criscuolo A, Ailloud F, Passet V, Jones L, Delannoy-Vieillard AS, Garin B, Le Hello S, Arlet G, Nicolas-Chanoine MH, Decré D, Brisse S.

Emerg Infect Dis. 2014 Nov;20(11):1812-20. doi: 10.3201/eid2011.140206.

20.

Development of a multiplex PCR assay for identification of Klebsiella pneumoniae hypervirulent clones of capsular serotype K2.

Bialek-Davenet S, Criscuolo A, Ailloud F, Passet V, Nicolas-Chanoine MH, Decré D, Brisse S.

J Med Microbiol. 2014 Dec;63(Pt 12):1608-14. doi: 10.1099/jmm.0.081448-0. Epub 2014 Sep 26.

PMID:
25261063
21.

Prevalence of Escherichia coli sequence type 131 and its H30 subclone among E. coli isolates in a French hospital.

Lafolie J, Nicolas-Chanoine MH, Grenouillet F, Hocquet D, Bertrand X.

Int J Antimicrob Agents. 2014 Nov;44(5):466-8. doi: 10.1016/j.ijantimicag.2014.07.016. Epub 2014 Sep 3.

PMID:
25241262
22.

Differential contribution of AcrAB and OqxAB efflux pumps to multidrug resistance and virulence in Klebsiella pneumoniae.

Bialek-Davenet S, Lavigne JP, Guyot K, Mayer N, Tournebize R, Brisse S, Leflon-Guibout V, Nicolas-Chanoine MH.

J Antimicrob Chemother. 2015 Jan;70(1):81-8. doi: 10.1093/jac/dku340. Epub 2014 Sep 4.

PMID:
25193085
23.

Matrix-assisted laser desorption ionization-time of flight mass spectrometry assigns Escherichia coli to the phylogroups A, B1, B2 and D.

Sauget M, Nicolas-Chanoine MH, Cabrolier N, Bertrand X, Hocquet D.

Int J Med Microbiol. 2014 Nov;304(8):977-83. doi: 10.1016/j.ijmm.2014.06.004. Epub 2014 Jul 7.

PMID:
25127424
24.

Faecal carriage of extended-spectrum β-lactamase (ESBL)-producing enterobacteria in liver disease patients from two hospitals in Egypt and France: a comparative epidemiological study.

Fam NS, Defasque S, Bert F, Leflon-Guibout V, El-Ray A, El-Ghannam M, Attia ME, Omar M, Desouki DG, Valla D, Nicolas-Chanoine MH.

Epidemiol Infect. 2015 Apr;143(6):1247-55. doi: 10.1017/S0950268814001812. Epub 2014 Jul 18.

PMID:
25036046
25.

Escherichia coli ST131, an intriguing clonal group.

Nicolas-Chanoine MH, Bertrand X, Madec JY.

Clin Microbiol Rev. 2014 Jul;27(3):543-74. doi: 10.1128/CMR.00125-13. Review.

26.

Incidence rates of carbapenemase-producing Enterobacteriaceae clinical isolates in France: a prospective nationwide study in 2011-12.

Robert J, Pantel A, Mérens A, Lavigne JP, Nicolas-Chanoine MH; ONERBA's Carbapenem Resistance Study Group.

J Antimicrob Chemother. 2014 Oct;69(10):2706-12. doi: 10.1093/jac/dku208. Epub 2014 Jun 16.

PMID:
24942333
27.

Molecular epidemiology of OXA-48-producing Klebsiella pneumoniae in France.

Liapis E, Pantel A, Robert J, Nicolas-Chanoine MH, Cavalié L, van der Mee-Marquet N, de Champs C, Aissa N, Eloy C, Blanc V, Guyeux C, Hocquet D, Lavigne JP, Bertrand X; ONERBA.

Clin Microbiol Infect. 2014 Dec;20(12):O1121-3. doi: 10.1111/1469-0691.12727. Epub 2014 Jul 29.

28.

Frequency and epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae isolates susceptible to third-generation cephalosporins or to aztreonam.

Bert F, Bialek-Davenet S, Leflon-Guibout V, Noussair L, Nicolas-Chanoine MH.

Med Mal Infect. 2014 Feb;44(2):76-8. doi: 10.1016/j.medmal.2013.12.004. Epub 2014 Feb 10.

PMID:
24525113
29.

Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains.

Blanc V, Leflon-Guibout V, Blanco J, Haenni M, Madec JY, Rafignon G, Bruno P, Mora A, Lopez C, Dahbi G, Dunais B, Anastay M, Branger C, Moreau R, Pradier C, Nicolas-Chanoine MH.

J Antimicrob Chemother. 2014 May;69(5):1231-7. doi: 10.1093/jac/dkt519. Epub 2014 Jan 8.

PMID:
24402502
30.

Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.

Bert F, Larroque B, Dondero F, Durand F, Paugam-Burtz C, Belghiti J, Moreau R, Nicolas-Chanoine MH.

Transpl Infect Dis. 2014 Feb;16(1):84-9. doi: 10.1111/tid.12169. Epub 2013 Dec 16.

PMID:
24330161
31.

Different factors associated with CTX-M-producing ST131 and non-ST131 Escherichia coli clinical isolates.

Nicolas-Chanoine MH, Robert J, Vigan M, Laouénan C, Brisse S, Mentré F, Jarlier V; Coli β study group.

PLoS One. 2013 Sep 4;8(9):e72191. doi: 10.1371/journal.pone.0072191. eCollection 2013.

32.

Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics.

Blanco J, Mora A, Mamani R, López C, Blanco M, Dahbi G, Herrera A, Marzoa J, Fernández V, de la Cruz F, Martínez-Martínez L, Alonso MP, Nicolas-Chanoine MH, Johnson JR, Johnston B, López-Cerero L, Pascual A, Rodríguez-Baño J; Spanish Group for Nosocomial Infections (GEIH).

J Clin Microbiol. 2013 Oct;51(10):3358-67. doi: 10.1128/JCM.01555-13. Epub 2013 Aug 7.

33.

Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.

Johnson JR, Tchesnokova V, Johnston B, Clabots C, Roberts PL, Billig M, Riddell K, Rogers P, Qin X, Butler-Wu S, Price LB, Aziz M, Nicolas-Chanoine MH, Debroy C, Robicsek A, Hansen G, Urban C, Platell J, Trott DJ, Zhanel G, Weissman SJ, Cookson BT, Fang FC, Limaye AP, Scholes D, Chattopadhyay S, Hooper DC, Sokurenko EV.

J Infect Dis. 2013 Mar 15;207(6):919-28. doi: 10.1093/infdis/jis933. Epub 2013 Jan 3.

34.

An adaptive response of Enterobacter aerogenes to imipenem: regulation of porin balance in clinical isolates.

Lavigne JP, Sotto A, Nicolas-Chanoine MH, Bouziges N, Pagès JM, Davin-Regli A.

Int J Antimicrob Agents. 2013 Feb;41(2):130-6. doi: 10.1016/j.ijantimicag.2012.10.010. Epub 2012 Dec 29.

PMID:
23280442
35.

10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum β-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre.

Nicolas-Chanoine MH, Gruson C, Bialek-Davenet S, Bertrand X, Thomas-Jean F, Bert F, Moyat M, Meiller E, Marcon E, Danchin N, Noussair L, Moreau R, Leflon-Guibout V.

J Antimicrob Chemother. 2013 Mar;68(3):562-8. doi: 10.1093/jac/dks429. Epub 2012 Nov 9.

PMID:
23143897
36.

Complete deletion of the ramR gene in an in vitro-selected mutant of Klebsiella pneumoniae overexpressing the AcrAB efflux pump.

Bialek-Davenet S, Leflon-Guibout V, Tran Minh O, Marcon E, Moreau R, Nicolas-Chanoine MH.

Antimicrob Agents Chemother. 2013 Jan;57(1):672-3. doi: 10.1128/AAC.01410-12. Epub 2012 Oct 22. No abstract available.

37.

The emergence of multidrug-resistant Klebsiella pneumoniae of international clones ST13, ST16, ST35, ST48 and ST101 in a teaching hospital in the Paris region.

Marcade G, Brisse S, Bialek S, Marcon E, Leflon-Guibout V, Passet V, Moreau R, Nicolas-Chanoine MH.

Epidemiol Infect. 2013 Aug;141(8):1705-12. doi: 10.1017/S0950268812002099. Epub 2012 Oct 4.

PMID:
23034125
38.

Microbiological and clinical characteristics of bacteraemia caused by the hypermucoviscosity phenotype of Klebsiella pneumoniae in Korea.

Bialek-Davenet S, Nicolas-Chanoine MH, Decré D, Brisse S.

Epidemiol Infect. 2013 Jan;141(1):188. doi: 10.1017/S0950268812002051. Epub 2012 Sep 25. No abstract available.

PMID:
23006593
39.

Phylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes.

Brisse S, Diancourt L, Laouénan C, Vigan M, Caro V, Arlet G, Drieux L, Leflon-Guibout V, Mentré F, Jarlier V, Nicolas-Chanoine MH; Coli β Study Group.

J Clin Microbiol. 2012 Sep;50(9):2974-81. Epub 2012 Jul 3.

40.

Pretransplant fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae and infection after liver transplant, France.

Bert F, Larroque B, Paugam-Burtz C, Dondero F, Durand F, Marcon E, Belghiti J, Moreau R, Nicolas-Chanoine MH.

Emerg Infect Dis. 2012 Jun;18(6):908-16. doi: 10.3201/eid1806.110139.

41.

Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009.

Johnson JR, Nicolas-Chanoine MH, DebRoy C, Castanheira M, Robicsek A, Hansen G, Weissman S, Urban C, Platell J, Trott D, Zhanel G, Clabots C, Johnston BD, Kuskowski MA; MASTER Investigators.

Emerg Infect Dis. 2012 Apr;18(4):598-607. doi: 10.3201/eid1804.111627.

42.

Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131.

Lavigne JP, Vergunst AC, Goret L, Sotto A, Combescure C, Blanco J, O'Callaghan D, Nicolas-Chanoine MH.

PLoS One. 2012;7(3):e34294. doi: 10.1371/journal.pone.0034294. Epub 2012 Mar 23.

43.

Patient's origin and lifestyle associated with CTX-M-producing Escherichia coli: a case-control-control study.

Nicolas-Chanoine MH, Jarlier V, Robert J, Arlet G, Drieux L, Leflon-Guibout V, Laouénan C, Larroque B, Caro V, Mentré F; Group Coli β.

PLoS One. 2012;7(1):e30498. doi: 10.1371/journal.pone.0030498. Epub 2012 Jan 27.

44.

Role of hepatic HCV-RNA level on the severity of chronic hepatitis C and response to antiviral therapy.

Maylin S, Laouénan C, Martinot-Peignoux M, Panhard X, Lapalus M, Nicolas-Chanoine MH, Bedossa P, Asselah T, Marcellin P.

J Clin Virol. 2012 Jan;53(1):43-7. doi: 10.1016/j.jcv.2011.09.029. Epub 2011 Nov 17.

PMID:
22099210
45.

Salmonella Colindale osteomyelitis in an immunocompetent female patient.

Lebeaux D, Zarrouk V, Petrover D, Nicolas-Chanoine MH, Fantin B.

Med Mal Infect. 2012 Jan;42(1):36-7. doi: 10.1016/j.medmal.2011.09.012. Epub 2011 Oct 21. No abstract available.

PMID:
22018944
46.

Do case vignettes accurately reflect antibiotic prescription?

Lucet JC, Nicolas-Chanoine MH, Lefort A, Roy C, Diamantis S, Papy E, Riveros-Palacios O, Le Grand J, Rioux C, Fantin B, Ravaud P.

Infect Control Hosp Epidemiol. 2011 Oct;32(10):1003-9. doi: 10.1086/661914. Epub 2011 Aug 10.

PMID:
21931251
47.

Membrane permeability, a pivotal function involved in antibiotic resistance and virulence in Enterobacter aerogenes clinical isolates.

Lavigne JP, Sotto A, Nicolas-Chanoine MH, Bouziges N, Bourg G, Davin-Regli A, Pagès JM.

Clin Microbiol Infect. 2012 Jun;18(6):539-45. doi: 10.1111/j.1469-0691.2011.03607.x. Epub 2011 Aug 29.

48.

In vitro selection of ramR and soxR mutants overexpressing efflux systems by fluoroquinolones as well as cefoxitin in Klebsiella pneumoniae.

Bialek-Davenet S, Marcon E, Leflon-Guibout V, Lavigne JP, Bert F, Moreau R, Nicolas-Chanoine MH.

Antimicrob Agents Chemother. 2011 Jun;55(6):2795-802. doi: 10.1128/AAC.00156-11. Epub 2011 Apr 4.

49.

Antibiotic use: knowledge and perceptions in two university hospitals.

Lucet JC, Nicolas-Chanoine MH, Roy C, Riveros-Palacios O, Diamantis S, Le Grand J, Papy E, Rioux C, Fantin B, Lefort A, Ravaud P.

J Antimicrob Chemother. 2011 Apr;66(4):936-40. doi: 10.1093/jac/dkq541. Epub 2011 Jan 26.

PMID:
21393217
50.

Detection of bacterial DNA in serum and ascitic fluid of asymptomatic outpatients with cirrhosis and non-neutrocytic ascites.

Sersté T, Bert F, Leflon-Guibout V, Chauvet C, Marcon E, Asselah T, Francoz C, Durand F, Lebrec D, Valla D, Moreau R, Nicolas-Chanoine MH.

Liver Int. 2011 Apr;31(4):494-8. doi: 10.1111/j.1478-3231.2011.02448.x. Epub 2011 Jan 30.

PMID:
21382159

Supplemental Content

Loading ...
Support Center